19-01-2017 20:00
via
pharmacypracticenews.com
FDA Approves ER Hydrocodone With Abuse Deterrence Technology
Vantrela ER is indicated to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Read more »